Exploring Mechanisms by Which Danggui Buxue Decoction Regulates Inflammation and Improves Renal Anemia Based on Network Pharmacology
Authors:
Open Access
- 11 May 2022
- journal article
- research article
- Published by SAGE Publications in Natural Product Communications
- Vol. 17 (5)
Abstract
Background: Renal anemia occurs frequently in patients with chronic kidney disease (CKD) and is related to chronic inflammation. Danggui Buxue Decoction (DBD) can treat anemia and improve the chronic inflammation. However, whether DBD treatment attenuates anemia by regulating inflammation in CKD patients with renal anemia is unknown. Therefore, this study explored inflammation-related network targets of DBD in renal anemia therapy and verified the interaction between DBD active ingredients and inflammatory proteins by molecular docking. Methods: The main effective components and targets of DBD were screened using the Traditional Chinese Medicine System Pharmacology Database and Analysis Platform. Renal anemia-related biomolecules were searched in the GeneCards, OMIM, TTD, Pharmgkb, and DrugBank databases. Protein-protein interaction (PPI) data were downloaded from the STRING database and core targets were obtained. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses for core targets were performed. Finally, active ingredients and core biomolecules were determined using molecular docking. Results: Twenty-two active components and 158 targets for DBD treatment of renal anemia were screened, and an “ingredient-target” network was constructed. Twenty core target genes were screened from the PPI data. Vascular endothelial growth factor A, Signal Transducer and Activator of transcription 1, C-X-C motif chemokine ligand 8, post-transcriptional gene silencing 2, and interleukin (IL)-1β were identified as inflammatory proteins. GO items related to inflammation and DBD included lipopolysaccharide, cellular response to chemical stress, and oxidative stress-related reactions. KEGG enrichment analyses showed that core inflammatory pathways mainly involved the IL-17 signaling pathway, tumor necrosis factor signaling pathway, and phosphoinositide 3-kinase-protein kinase B signaling pathway. Molecular docking results indicated that the binding energy of quercetin, an active ingredient of DBD, to the 5 core proteins was less than −6 kcal·mol−1. Conclusion: DBD might have protective effects against renal anemia by improving inflammation. Quercetin might modulate multiple inflammatory proteins and pathways.Keywords
Funding Information
- Project of Science and Technology Department of Guangdong Province (2016A020226042)
This publication has 21 references indexed in Scilit:
- Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout miceAmerican Journal of Physiology-Renal Physiology, 2016
- Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney diseaseMedicine, 2016
- Computational protein–ligand docking and virtual drug screening with the AutoDock suiteNature Protocols, 2016
- Hepcidin-Induced Endocytosis of Ferroportin Is Dependent on Ferroportin UbiquitinationCell Metabolism, 2012
- Hepcidin in Human Iron Disorders: Diagnostic ImplicationsClinical Chemistry, 2011
- Contribution of the Per/Arnt/Sim (PAS) Domains to DNA Binding by the Basic Helix-Loop-Helix PAS Transcriptional RegulatorsJournal of Biological Chemistry, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a geneNucleic Acids Research, 2000
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.Proceedings of the National Academy of Sciences, 1991